Three staff members in ORNL’s Fusion and Fission Energy and Science Directorate have moved into newly established roles facilitating communication and program management with sponsors of the directorate’s Nuclear Energy and Fuel Cycle Division.
Scientists at ORNL are looking for a happy medium to enable the grid of the future, filling a gap between high and low voltages for power electronics technology that underpins the modern U.S. electric grid.
From July 15 to 26, 2024, the Department of Energy’s Oak Ridge National Laboratory will host the second U.S. Quantum Information Science, or QIS, Summer School.
New computational framework speeds discovery of fungal metabolites, key to plant health and used in drug therapies and for other uses.
ORNL’s successes in QIS and its forward-looking strategy were recently recognized in the form of three funding awards that will help ensure the laboratory remains a leader in advancing quantum computers and networks.
The INFUSE fusion program announced a second round of 2020 public-private partnership awards to accelerate fusion energy development.
East Tennessee occupies a special place in nuclear history. In 1943, the world’s first continuously operating reactor began operating on land that would become ORNL.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
Chuck Kessel was still in high school when he saw a scientist hold up a tiny vial of water and say, “This could fuel a house for a whole year.”
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.